TerrAscend Corp. (TSX:TSND)
0.6700
-0.0100 (-1.47%)
Oct 14, 2026, 4:00 PM EST
TerrAscend Market Cap
TerrAscend has a market cap or net worth of CAD 207.15 million as of October 14, 2026. It is the 22,828th most valuable company in the world and the 584th biggest in Canada. Its market cap has decreased by 39.50% in one year.
Market Cap
207.15M
Enterprise Value
499.58M
Revenue
374.77M
Global Rank
Country Rank
#584 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 3, 2017, TerrAscend's market cap has increased from 35.38M to 207.15M, an increase of 485.54%. That is a compound annual growth rate of 20.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 207.15M | -31.23% |
| Dec 31, 2025 | 301.20M | 12.48% |
| Dec 31, 2024 | 267.77M | -57.63% |
| Dec 29, 2023 | 632.00M | 57.35% |
| Dec 30, 2022 | 401.64M | -72.92% |
| Dec 31, 2021 | 1.48B | -24.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 343.10M |
| Auxly Cannabis Group | 338.61M |
| Cresco Labs | 333.87M |
| Cannara Biotech | 208.29M |
| Cardiol Therapeutics | 199.77M |
| Organigram Global | 186.13M |
| BioSyent | 180.60M |
| Medexus Pharmaceuticals | 151.47M |